OxyContin, the opium derivative of choice for half a million people aged 12 or older, is slated to go generic next month. Though the new iteration of the drug will in many ways resemble the brand-name version, it does come with one feature that ups its street value considerably: it's crushable.
Whereas name-brand OxyContin turns either crumbly or gelatinous when mashed up—a feature intentionally implemented to deter addicts— the knock-off stuff converts seamlessly into powder, perfect for those who favor the Hannah Horvath approach to drug-consumption (in lines, off the toilet seat of a public restroom, while wearing a yellow mesh tank top (optional)).
Several politicians are moving to quash the drug before it hits shelves, with the most recent opponent being Sen. Charles Schumer, who yesterday decried the release of the new pill on the basis that it lacks the safeguards that come with the name-brand. The Post reported that Schumer referred to the drug as an "addict's dream" thanks to its snort-friendly texture.
According to SI Live.com, Schumer is imploring the FDA to require the same deterrents as the brand-name pills, which it does not.
"Pills that are easily crushed or altered are far more valuable than the versions that can't be tampered with, making pharmacies and people that carry them a target for violent thieves," the senator said. "The FDA should ensure that these generic pills have equivalent protections as their branded counterparts, for everyone's safety."
According to Newsday, 48 state attorneys general have already appealed to the FDA to mandate the anti-abuse measures.
Schumer delivered his presser outside a East Harlem drugstore, though he really should have held it on Staten Island. After all, only one borough maintains such an affection for the drug that its residents felt moved to produce an entire music video in its honor.
